Subscribe
marilyn-nieves
marilyn-nieves / iStockphoto.com
7 September 2017Americas

PhRMA and BIO take legal action against Nevada law

Two biotech associations have filed litigation in a district court challenging the provisions of a Nevada law, saying it violates patent rights.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug